Zoom On: Dr. Todd Dorman - ICU Management Editorial Board Member
We put our 7 questions to Dr. Dorman:
1. What are your key areas of interest and research?
The intersection of adult education, technology and clinical practice improvement.
2. What are the major challenges in your field?
Changing the paradigm from passive to active education models and engaging the entire team.
3. What is your top management tip?
Communicate, communicate, communicate.
4. What would you single out as a career highlight?
Every small victory against disease at the bedside.
5. If you had not chosen this career path you would have become a...?
6. What are your personal interests outside of work?
Family, sports, reading, and cooking.
7. Your favourite quote?
Success is the pathway not the endpoint.
Todd Dorman, MD, FCCM, is Board Certified in Internal Medicine, Anaesthesiology and with special qualifications in Critical Care Medicine. He is the Senior Associate Dean for Education Coordination and the Associate Dean for Continuing Medical Education for the Johns Hopkins School of Medicine in Baltimore, Maryland. He is a Professor and Vice Chair for Critical Care in the Department of Anesthesiology and Critical Care Medicine, and has joint appointments as a Professor in Internal Medicine, Surgery and The School of Nursing. Previously he served as the Director of the Division of Adult Critical Care Medicine, Co-Director of the Surgical Intensive Care Units, Medical Director of the Adult Post-anesthesiology Care Units and Medical Director of Respiratory Care Services. Presently he serves on the institutional Steering Committees for Innovation and Safety and for the Simulation Center. He also co-chairs the committee on interactions with industry, and serves on the conflict of commitment committee.
Dr. Dorman has served on the Anesthesiology and Respiratory Device Committee of the U.S. Food and Drug Administration (FDA), and was a member of the Institute of Medicine (IOM) Committee on Conflict of Interest in Education, Research and Practice. He serves as the editor of several scientific journals and sits on numerous editorial boards including Critical Care Medicine and the Journal for Continuing Education in the Health Professions. He has an extensive background in association leadership, and has served as the President of the American Society for Critical Care Anesthesiologists (ASCCA) and President of the Society for Academic CME (SACME). He is also a member of the American Society for Association Executives (ASAE). He serves on the Board of Directors of the Accreditation Council for CME (ACCME), and started his service in March 2012.
Dr. Dorman joined the Society for Critical Care Medicine (SCCM) in 1988, and has served on and subsequently chaired numerous committees and task forces. He presently serves as Treasurer of SCCM. He also has participated in and helped lead guideline writing groups for the American College of Critical Care Medicine, for which he was inducted as a member in 1997.
Dr. Dorman has lectured extensively on the Value of CME. He has also delivered keynote and plenary lectures on leadership and helped establish the inaugural Summer Leadership Institute for SACME.
Dr. Dorman's ICU-oriented research interests include informatics applications in the ICU such as remote monitoring of critically ill patients, leadership strategies in the ICU, and creation of a culture of safety, and he has published extensively in all of these areas. He served as Co-Principal Investigator on the Agency for Healthcare Research & Quality (AHRQ)-funded project on the Effectiveness of CME. He has won the Fox Award for Research from SACME, and an opinion piece on the future of CME was chosen in 2012 by the editor of Academic Medicine for an oral presentation at the annual meeting.
Dr. Dorman has served as a mentor to numerous clinical and research fellows, many of whom have gone on to contribute significantly to healthcare in a variety of roles that include industry, but importantly leadership in academic health centres (Jeff Balser, MD, PhD) and in the field of quality and safety (Peter Pronovost, MD, PhD).
Dr. Dorman is happily married with two wonderful children. He loves sports and the sun, which he says comes from being born and growing up in Florida. He is a diehard Ravens (American football) and Orioles (baseball) fan, and follows international football closely.
Dorman T, Paudline R. Communication with the administration. ICU Management 6(1): 34-5.
Dorman T, Pauldine R (2006) Billing and documentation: a primer. ICU Management, 6(1): 60. er
Pauldine R, Dorman T (2006) Communication with families in the ICU. ICU Management, 6(2): 31-2.
Dorman T, Pauldine R (2006) Motivating staff. ICU Management, 6(3): 29-30.
Pauldine R, Dorman T (2007) Change management: part 1 - sources of and barriers to change. ICU Management, 7(2): 30-1.
Pauldine R, Dorman T (2007) The disaster "cascade": burnout syndrome in the ICU. ICU Management, 7(1): 14.
Update 7/2016: Since Prof. Dorman's profile was published, he became President of the Society of Critical Care Medicine, serving a 1 year term from February 2016. Read an interview with Prof. Dorman in ICU Management & Practice.
Published on : Mon, 18 Aug 2014
FeaturesSV 300 is a state-of-the-art ventilator that’s simple to configure, easy to operate and versatile in use. It equips with extensive ventilation modes that can treats pediatric and adult patients with all acuity levels at ICUs and Intermediate Care.With...
Features The SynoVent E5 is the ventilator you need with the interface you want. It does not only include advanced ventilator functionality for patients ranging from infant to adult, but also a modern, easy-to-use interface. The display can be configured...
Q-NRG is the first Indirect Calorimeter specifically intended for the measurement of Resting Energy Expenditure (REE) in patients who are mechanically ventilated or spontaneously breathing and for healthy subjects.Q-NRG is a unique product, resulting...
The fully-automated Accelerate Pheno™ system is designed to eliminate the lengthy culture and sample preparation steps required for most sample types prior to antimicrobial susceptibility testing. In addition, it hosts proprietary molecular identification...
XENIOS AG is a medical device company with the three brands, novalung, i-cor and medos, that run on a single XENIOS platform. This platform enables next-generation therapies for lung and heart failure. No other company except XENIOS AG is offering lung...